Passive income is the paycheck that arrives whether you show up or not. Wages depend on a functioning employer, a healthy economy, and the continued willingnessPassive income is the paycheck that arrives whether you show up or not. Wages depend on a functioning employer, a healthy economy, and the continued willingness

$500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The post $500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income appeared first on 24/7 Wall St..

  • Pfizer (PFE), PepsiCo (PEP), and Johnson & Johnson (JNJ) combined generate over $6,700 annual passive income on $150,000 investment.
  • A $50,000 investment in Pfizer yields approximately $3,601 annual passive income at its 7.20% dividend yield rate.
  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Johnson & Johnson didn't make the cut. Grab the names FREE today.

Passive income is the paycheck that arrives whether you show up or not. Wages depend on a functioning employer, a healthy economy, and the continued willingness of both to keep the seat warm. Dividend income depends on a company writing a check every 90 days, and for a handful of blue chips, that check has arrived without interruption for more than half a century.

Real estate can deliver similar cash flow, but it comes with tenants, repairs, and closing costs measured in weeks. High-yield dividend stocks settle in seconds, can be sold in any size, and require no phone calls at midnight. For an income-focused investor, that liquidity premium is often worth more than the last basis point of yield.

We screened our 24/7 Wall St. dividend equity research database, looking for stocks that pay massive dividends, and we found a collection of companies that, combined, can generate over $6,700 a year in passive annual income if you invest just $50,000 in each stock at the time of this writing.

Johnson & Johnson

  • Yield: 2.11%
  • Shares for $50,000: 196.87
  • Annual Passive Income: $1,055

Johnson & Johnson (NYSE:JNJ) is a $611 billion diversified healthcare business split across Innovative Medicine (oncology franchises like DARZALEX, TREMFYA, and CARVYKTI) and MedTech (Cardiovascular, Orthopaedics, Surgery, and Vision).

The company generated $24.06 billion in Q1 2026 revenue, up 9.9% year over year, and raised full-year guidance to $100.3 billion to $101.3 billion in sales.

The yield sits on the lower end of this list because the underlying business is a triple-A cash machine. That said, JNJ raised its quarterly payout 3.1% to $1.34 per share in Q1, extending its streak to 64 consecutive years of dividend increases, the longest track record in big pharma. Institutions own 76.83% of the float, led by Vanguard, BlackRock, and State Street.

PepsiCo

  • Yield: 4.19%
  • Shares for $50,000: 354.21
  • Annual Passive Income: $2,097

PepsiCo (NASDAQ:PEP) is the global snacks-and-beverages operator behind Pepsi, Lay’s, Doritos, Gatorade, Mountain Dew, Quaker, Cheetos, Tropicana, and poppi, split across six reporting segments. Q1 2026 revenue came in at $19.44 billion with core EPS of $1.61, beating consensus by 4.26%.

The yield has drifted higher on multi-quarter share-price weakness. Management just pushed the annualized dividend 4% higher to $5.92 per share starting with the June 2026 payment, the 54th consecutive annual increase, and authorized a new $10 billion share repurchase program through February 28, 2030.

FY26 cash returns are guided to $8.9 billion. Institutions hold 80.92% of shares, with Vanguard and BlackRock again the largest holders.

Pfizer

  • Yield: 7.20%
  • Shares for $50,000: 2,093.80
  • Annual Passive Income: $3,601

Pfizer (NYSE:PFE) is a global biopharma running three commercial engines: Primary Care (Eliquis, Prevnar, Nurtec ODT, Abrysvo), Oncology (Ibrance, Padcev, Xtandi, Lorbrena, plus the Seagen assets), and Specialty Care (the Vyndaqel family). Q1 2026 revenue reached $14.45 billion, up 5.4% year over year, with adjusted EPS of $0.75 topping estimates.

The elevated yield reflects the post-COVID revenue reset from Comirnaty and Paxlovid. Management is prioritizing the payout and deleveraging over buybacks: $3.3 billion in repurchase authorization remains untouched with none planned for 2026.

The quarterly is $0.43 per share, held steady across 8 consecutive quarters, and the Vyndamax patent settlement extends U.S. exclusivity to June 2031.

The bottom line 

Combined, these 3 positions generate $6,753 in annual passive income on a $150,000 investment, a blended yield of 4.50%. Pfizer contributes $3,601, PepsiCo adds $2,097, and Johnson & Johnson rounds out the portfolio with $1,055.

An infographic titled 'Here's What $500 a Month in These Stocks Will Generate For You' displays a portfolio overview and detailed information for three dividend stocks. The 'Portfolio Overview' section includes a donut chart showing the share of total annual income: PFE (Pfizer) at 53.3%, PEP (PepsiCo) at 31.1%, and JNJ (Johnson & Johnson) at 15.6%. The total annual income is ~$6,753 from a total investment of $150,000 ($50,000 per stock), with a blended yield of 4.50%. Individual stock details are presented: 1. Pfizer (NYSE: PFE): 7.20% dividend yield, ~$3,601 annual passive income. Investment: $50,000 | Shares: 2,093.80. Key facts include a quarterly dividend of $0.43 (held steady for 8 consecutive quarters) and a Vyndamax patent settlement extending U.S. exclusivity to June 2031. 2. PepsiCo (NASDAQ: PEP): 4.19% dividend yield, ~$2,097 annual passive income. Investment: $50,000 | Shares: 354.21. Key facts include its 54th consecutive annual increase in dividend, an annualized dividend raised 4% to $5.92 per share, and a new $10 billion share repurchase program. 3. Johnson & Johnson (NYSE: JNJ): 2.11% dividend yield, ~$1,055 annual passive income. Investment: $50,000 | Shares: 196.87. Key facts include 64 consecutive years of dividend increases, a quarterly payout raised 3.1% to $1.34 per share, and Q1 2026 revenue of $24.06 billion, up 9.9% YoY. The 'Investment Benefits' section lists 'Dividend Compounding' and 'Liquidity Premium'. A disclaimer at the bottom states 'Data as of July 2, 2026. Source: 24/7 Wall St. Dividend Equity Research Database. Not financial advice.'24/7 Wall St.
Ticker Annual Income Share of Total
PFE $3,601 53.3%
PEP $2,097 31.1%
JNJ $1,055 15.6%
Total $6,753 100%

Reinvest every distribution rather than spending it, and the share count grows quarter after quarter without a single additional dollar of fresh capital. That compounding is what separates a dividend portfolio from a bond ladder: the coupon size expands on its own. For investors building toward a future income floor, three checks a year from three separate industries is a durable place to start.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Johnson & Johnson didn’t make the cut. Grab the names FREE today.

The post $500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income appeared first on 24/7 Wall St..

Market Opportunity
Notcoin Logo
Notcoin Price(NOT)
$0.0003868
$0.0003868$0.0003868
-0.41%
USD
Notcoin (NOT) Live Price Chart

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.